Blackrock Health Sciences Trust is a US-based company operating in industry. The company is headquartered in Wilmington, Delaware. The company went IPO on 2005-03-29. BlackRock Health Sciences Trust (the Trust) is a closed-end management investment company. The Trust investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry. The Trust seeks to pursue this goal primarily by investing in a portfolio of equity securities and by employing a strategy of writing (selling) call and put options. The Trust invests in a portfolio of sectors, which include pharma, biotech and life sciences; healthcare equipment and services; semiconductors & semiconductor equipment; financial services, and others. BlackRock Advisors, LLC acts as the investment adviser of the Trust.
根据最新的财务报表(Form-10K),Blackrock Health Sciences Trust 的总资产为 $0,净损失为 $0
BME 的关键财务比率是什么?
Blackrock Health Sciences Trust 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
Blackrock Health Sciences Trust 的收入按细分市场或地理位置如何划分?
Blackrock Health Sciences Trust 最大收入来源是 Dietary Supplements,在最近的收益报告中收入为 384,078。就地区而言, United States 是 Blackrock Health Sciences Trust 的主要市场,收入为 384,078。
Blackrock Health Sciences Trust 是否盈利?
不,根据最新的财务报表,Blackrock Health Sciences Trust 的净损失为 $0